One dose of HPV vaccine is noninferior to two doses

Key Points

• To evaluate whether one dose of the HPV vaccine is as effective as two doses in terms of immunogenicity.
• Clinical trial comparing one dose versus two doses of HPV vaccine
• Assessment of immune response at specified intervals
• Data analysis focused on noninferiority standards
• One dose demonstrated immunogenicity levels comparable to two doses
• No significant differences in antibody response between groups
• Indicated feasibility for reducing the complexity of vaccination schedules